单细胞长读长转录本基因分型揭示MPN后AML克隆演化机制
研究开发了长读长转录本基因分型技术LOTR-Seq,可同时检测30个基因的全长表达转录本。对8例慢性期MPN和4例MPN后AML患者的造血干祖细胞进行单细胞分析,将JAK2V617F等突变与转录组关联,揭示了MPN后AML克隆演化的离散机制。
要点
- LOTR-Seq可同时基因分型30个基因的全长转录本,克服低表达基因检测难题。
- 在MPN后AML中鉴定出JAK2、IDH1/2、TP53、SRSF2、U2AF1共6基因9个突变位点。
- 突变与特定转录表型关联,为理解克隆演化提供新视角。
核心结论
- LOTR-Seq为MPN后AML的演化提供了新见解。
研究设计与样本
- 开发长读长转录本基因分型流程LOTR-Seq,可同时检测30个基因的全长表达转录本。
- 对8例慢性期MPN患者的9075个单细胞和4例MPN后AML患者的5016个细胞进行JAK2V617位点基因分型。
主要发现
- 在MPN后AML分析中,鉴定出6个基因(JAK2、IDH1/2、TP53、SRSF2、U2AF1)的9个突变位点。
- 这些突变与特定的转录表型相关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myeloproliferative neoplasms (MPNs) are caused by acquired mutations in hematopoietic stem and progenitor cells (HSPCs). The acquisition of additional mutations, such as TP53, and the overall mutational burden influence a patient's risk of disease progression to lethal post-MPN acute myeloid leukemias (AML). Recent technological advancements in linking single-cell gene expression with genotype have improved our understanding of tumor heterogeneity. However, current methodologies have limitations in simultaneously genotyping low-expression genes (such as JAK2) alongside other pathogenic loci. To address this, we developed a novel long-read genotyping pipeline of complementary DNA transcripts (long-read genotyping of transcripts [LOTR]-Seq), which can genotype the full length of expressed transcripts from 30 genes at once. Using LOTR-Seq, we genotyped HSPCs at the JAK2V617 locus in 9075 single cells from 8 patients with chronic-phase MPN (CP-MPN) and in 5016 cells from 4 patients with post-MPN AML. We then linked the mutations to the single-cell transcriptomes of 29 712 JAK2V617F-driven CP-MPN cells and 16 895 post-MPN AML cells. In our analysis of post-MPN AML, we identified 9 mutated loci across 6 genes (JAK2, IDH1/2, TP53, SRSF2, and U2AF1) and linked these mutations to specific transcriptional phenotypes. Overall, LOTR-Seq provides novel insights into the evolution of post-MPN AML.
引用
- Grabek J, Straube J, Cooper L, et al. Single-cell long-read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-MPN AML. Blood Adv. 2026. PMID: 42101375. doi:10.1182/bloodadvances.2025018902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。